New active substance distribution by disease 1996-2020

This statistic shows the projected distribution of new active substances available between 1996 and 2020, sorted by disease group. It is estimated that some 24 percent of new active substances will be available for treating orphan diseases during that period.

Projected distribution of global available new active substances by disease type between 1996 and 2020*

Characteristic	Percentage of new active substances available
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2015

More information

Region

Worldwide

Survey time period

1996 to 2015

Supplementary notes

Note: Disease categories based on therapy areas and expected launches 2016-20. Orphan drugs are those to treat small populations with rare diseases, and are defined separately by U.S. FDA and the European Medicines Agency (EMA). Any medicine with an orphan designation for an approved use within the first year after global launch are categorized as Orphan. Half of designated orphan indications are granted more than a year after original approval.

Citation formats